.jpg)
STAT Plus: Stunning FDA rejection signals potential new hurdles for gene therapies
The Food and Drug Administration’s unexpected rejection of a gene therapy for the bleeding disorder…
Author: STAT
Ramped-up testing and daily briefings: Inside Biden’s plan to take over a tumultuous Covid-19 response
WASHINGTON — No president has ever inherited a pandemic. But if Joe Biden is elected…
STAT Plus: Otsuka approved to buy bankrupt smart-pill maker Proteus’ assets, overcoming effort by Novartis to block purchase
The Japanese drug maker Otsuka has been approved to purchase the assets of bankrupt smart…
STAT Plus: After FDA rejection of a key drug, is Gilead still a turnaround story?
The surprise decision by the FDA to reject a Gilead Sciences (GILD) drug for treating…
New research tabs a natural byproduct of metabolism as a potent trigger of cancer spread
Aging is the biggest risk factor for cancer: The older we get, the more likely…
STAT Health Tech: How Teladoc won and Lyft’s Medicaid transportation business
A version of this digest first appeared in the weekly STAT Health Tech newsletter. To…
STAT Plus: Pharmalittle: FDA surprises BioMarin and Gilead by rejecting key drugs; J&J pays $6.5 billion to buy Momenta
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
STAT Plus: Turning Point releases positive data for targeted cancer drug, points to more rapid FDA filing
Turning Point Therapeutics, a San Diego developer of targeted cancer drugs, released positive data Wednesday…
.jpg)
STAT Plus: In a shocking decision, FDA rejects BioMarin’s gene therapy for hemophilia
The Food and Drug Administration on Wednesday rejected a one-time therapy for hemophilia A, delaying…
STAT Plus: J&J to buy Momenta Pharma in a bid to bolster autoimmune disease pipeline
Health care giant Johnson & Johnson said Wednesday that it is acquiring Momenta Pharmaceuticals, gaining…
STAT Plus: An expected blockbuster drug from Gilead is rejected, imperiling the biotech’s future growth
Back before remdesivir became a household name, Gilead Sciences’ most-discussed drug was filgotinib, a treatment…
Opinion: It’s time to stop using skin color and race in medicine and see patients for who they really are
My parents fell in love at a time when their union was illegal in 16…
Will Covid-19 vaccines be safe for children and pregnant women? The data, so far, are lacking
As potential Covid-19 vaccines speed their way through development, manufacturers and U.S. regulators have largely…
STAT Plus: Federal prosecutors allege Teva used charities to pay kickbacks to Medicare patients
Federal authorities alleged that Teva Pharmaceuticals (TEVA) donated hundreds of millions of dollars to a…
STAT Plus: FDA finalizes penalties for trial sponsors that don’t share data, but critics say the effort falls short
After a year of deliberation, the Food and Drug Administration released final guidelines for penalizing…
STAT China: A debut for CanSino Biologics and Cellular BioMed’s controversy
A version of this digest first appeared in the weekly STAT China newsletter. To receive…
Virtual Event: AI: Cracking Covid-19’s Code
Editor’s note: A live stream of this virtual event will be embedded above at 1…
STAT Plus: Pharmalittle: Trump touts an unproven salve for Covid-19; states seek big bucks to settle opioid suits
Hello, everyone, and how are you today? A bright shiny sun and cool breezes are…
LGBTQ youth say cost, parental permission pose major barriers to mental health care
The Covid-19 pandemic stands to exacerbate the existing mental health crisis among LGBTQ youth, who…
Trump campaign’s Facebook ad blitz casts Biden as pharma’s preferred candidate
WASHINGTON — President Trump’s reelection campaign is appealing to swing voters by attacking “Big Pharma”…
Opinion: ICU capacity is more about the clinicians than the number of beds
Each time communities experience surges of Covid-19, concerns arise over the availability of hospital and…
STAT Plus: How Teladoc won: The inside story of how well-timed bets propelled it ahead of the competition
The unquestioned leader in a virtual care sector that has surged in the Covid-19 era,…
How do you separate scientifically sound stem cell therapies from scams?
For patients who’ve run out of other options, experimental, unproven therapies like stem cell treatments…
STAT Plus: Applied Therapeutics’ muted response to a clinical hold speaks volumes
How a company communicates with investors can be just as meaningful as what it communicates….
STAT Plus: Opioid prescriptions written for Medicare Part D beneficiaries continues to drop
Amid an ongoing opioid crisis in the U.S., a new federal government report finds that…
STAT Plus: Q&A: Sanofi CEO Paul Hudson on a major acquisition, long-term strategy, and Covid-19 vaccines
It was less than 12 months ago that Paul Hudson took the reins at the…
STAT Plus: Pharmalittle: U.S. ties Covid-19 vaccine payments to milestones; Sanofi spends $3.7 billion for Principia and an MS drug
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Unity Biotechnology fails early test, raising doubts its ability to develop drugs to reverse aging symptoms
Unity Biotechnology said Monday that its experimental treatment for osteoarthritis failed to improve knee pain…
STAT Plus: CytoDyn is in financial and clinical distress, newly filed annual report shows
An annual report disclosed by CytoDyn on Friday night describes a drug maker in distress….
Opinion: Telehealth and the new choreography of ‘anywhere care’
Covid-19 has transformed the traditional doctor’s office visit as we know it, moving it away…
Watch: What day is it? How pandemic stress alters your perception of time
Sunday, Monday, July, August — do these words still have meaning? Time can feel like…
Seven months later, what we know about Covid-19 — and the pressing questions that remain
The “before times” seem like a decade ago, don’t they? Those carefree days when hugging…
STAT Plus: Sanofi, aiming to speed MS treatment, to acquire Principia Biopharma for $3.68 billion
Sanofi said Monday that it is acquiring Principia Biopharma for $3.68 billion, giving the French…
FDA clears saliva test for Covid-19, opening door to wider testing
The Food and Drug Administration on Saturday authorized emergency use of a new and inexpensive…
STAT Plus: Medicaid beneficiaries sue Texas health agency for restricting access to hepatitis C medicines
A group of Medicaid enrollees is accusing a Texas agency of rationing hepatitis C medicines…
STAT Plus: CureVac’s value soars after IPO, as Covid-19 vaccine manufacturers become biotech’s hottest companies
The developer of a vaccine for Covid-19 saw its share price nearly triple within hours…
STAT Plus: Pharmalittle: Governments race to acquire Covid-19 vaccines; top Russian doctor quits over vaccine ethics
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Johnson & Johnson invests in Thirty Madison, signaling the resilience of pharma’s interest in health tech
Late last year, several high-profile partnerships between big pharma companies and health tech startups fell…
Opinion: Going viral: What Covid-19-related loss of smell reveals about how the mind works
A few months ago, a friend called me from New York in the middle of…
Covid-19 clinical trials are are failing to enroll diverse populations, despite awareness efforts
It’s been well-established that Covid-19, at least in the United States, has disproportionately affected people…
‘A powerful shift’: Disability advocacy, once an afterthought in presidential races, gains new traction
For decades, the disability advocacy community has fought for a permanent — and prominent —…
Listen: Pharma’s lobbying dollars, Alnylam’s future, and diversity in Covid-19 studies
Is pharma scared of Kamala Harris? Are there second acts in biotech? And why aren’t…
STAT Plus: Teladoc rival MDLive is preparing to go public next year
On the heels of Teladoc’s landscape-shifting deal to buy Livongo, telemedicine rival MDLive is setting…
STAT Plus: Doctors say antibiotic resistance is an issue — but most say they’re not part of the problem
Amid growing concerns over antibiotic resistance, a new survey finds the vast majority of doctors…
Opinion: Lung cancer deaths are declining faster than new cases. Advances in treatment are making the difference
This year’s annual release of cancer statistics generated more buzz than usual. Perhaps the most…
STAT Plus: Many psoriasis patients are paying higher prices than ever at the pharmacy counter
Over the past decade, wholesale prices for self-administered psoriasis medicines rose substantially, underscoring the ongoing…
Large study suggests convalescent plasma can help treat Covid-19, with caveats
Infusing hospitalized Covid-19 patients with blood plasma from people who recovered from the disease appeared…
STAT Plus: Pharmalittle: FDA approves another Duchenne muscular dystrophy drug; European orphan drug incentives questioned
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Opinion: Instead of lockdowns, teach people how to socialize safely in the time of coronavirus
In response to the rising Covid-19 death toll and case counts in the U.S., calls…
The Trump administration haphazardly gave away millions of Covid-19 masks — to schools, broadcasters, and large corporations
Hundreds of millions of cloth face masks shipped to U.S. agencies, nonprofit organizations, and private…